FDA Warning Letter — Natuzen Co., Ltd.

Case 677942 — FEI 3006731547

The FDA took a Warning Letter action against Natuzen Co., Ltd. on May 3, 2024 (Namdong District, South Korea). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Natuzen Co., Ltd.
Date
May 3, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Namdong District (South Korea)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.